Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2018-05-08
2020-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, patients will undergo body composition monitoring assessing systemic fluid overload and T1-mapping using MOLLI by cardiovacular magnetic resonance imaging in order to investigate a possible association with each other.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661
Association of T1-mapping and LV Strain Analysis by CMR
NCT03405987
Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods
NCT01934699
International T1 Multicentre CMR Outcome Study
NCT02407197
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
NCT04444128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluid overload (Liters) ≥ median
Bioimpedance spectroscopy
Fluid overload will be assessed by bioimpedance spectroscopy
Fluid overload (Liters) < median
Bioimpedance spectroscopy
Fluid overload will be assessed by bioimpedance spectroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bioimpedance spectroscopy
Fluid overload will be assessed by bioimpedance spectroscopy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient undergoing cardiovascular magnetic resonance imaging
Exclusion Criteria
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Andreas Kammerlander
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andreas Kammerlander, MD PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCM-CMR-T1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.